Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Peringkat dalam Saham #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Harga Saham
$93.80
Terakhir disinkronkan: 2025-04-28
Kapitalisasi Pasar
$2.68B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Aerovate Therapeutics, Inc. (AVTE)

Kategori

Riwayat harga saham Aerovate Therapeutics, Inc. (AVTE)
Harga penutupan tertinggi: $92.05 pada 2025-04-01

Harga penutupan terendah: $799.05 pada 2021-06-01
Riwayat harga saham Aerovate Therapeutics, Inc. dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2025 1.25%
2024 -86.27%
2023 -23.84%
2022 125.16%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$762.91 6.87%
CH